597 related articles for article (PubMed ID: 27258614)
1. Protective efficacy of a recombinant bacterial artificial chromosome clone of a very virulent Marek's disease virus containing a reticuloendotheliosis virus long terminal repeat.
Mays JK; Black-Pyrkosz A; Spatz S; Fadly AM; Dunn JR
Avian Pathol; 2016 Dec; 45(6):657-666. PubMed ID: 27258614
[TBL] [Abstract][Full Text] [Related]
2. Insertion of reticuloendotheliosis virus long terminal repeat into a bacterial artificial chromosome clone of a very virulent Marek's disease virus alters its pathogenicity.
Mays JK; Silva RF; Kim T; Fadly A
Avian Pathol; 2012; 41(3):259-65. PubMed ID: 22702453
[TBL] [Abstract][Full Text] [Related]
3. Artificially inserting a reticuloendotheliosis virus long terminal repeat into a bacterial artificial chromosome clone of Marek's disease virus (MDV) alters expression of nearby MDV genes.
Kim T; Mays J; Fadly A; Silva RF
Virus Genes; 2011 Jun; 42(3):369-76. PubMed ID: 21340512
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Md5-BAC-REV-LTR virus as Marek's disease vaccine in commercial meat-type chickens: protection and immunosuppression.
Ellington C; Cortes AL; Faiz NM; Mays JK; Fadly A; Silva RF; Gimeno IM
Avian Pathol; 2021 Dec; 50(6):490-499. PubMed ID: 34463588
[TBL] [Abstract][Full Text] [Related]
5. Properties of a meq-deleted rmd5 Marek's disease vaccine: protection against virulent MDV challenge and induction of lymphoid organ atrophy are simultaneously attenuated by serial passage in vitro.
Lee LF; Kreager K; Heidari M; Zhang H; Lupiani B; Reddy SM; Fadly A
Avian Dis; 2013 Jun; 57(2 Suppl):491-7. PubMed ID: 23901766
[TBL] [Abstract][Full Text] [Related]
6. A recombinant field strain of Marek's disease (MD) virus with reticuloendotheliosis virus long terminal repeat insert lacking the meq gene as a vaccine against MD.
Su S; Cui N; Zhou Y; Chen Z; Li Y; Ding J; Wang Y; Duan L; Cui Z
Vaccine; 2015 Jan; 33(5):596-603. PubMed ID: 25562789
[TBL] [Abstract][Full Text] [Related]
7. Insertion of reticuloendotheliosis virus long terminal repeat into the genome of CVI988 strain of Marek's disease virus results in enhanced growth and protection.
Lupiani B; Lee LF; Kreager KS; Witter RL; Reddy SM
Avian Dis; 2013 Jun; 57(2 Suppl):427-31. PubMed ID: 23901756
[TBL] [Abstract][Full Text] [Related]
8. Protection provided by Rispens CVI988 vaccine against Marek's disease virus isolates of different pathotypes and early prediction of vaccine take and MD outcome.
Ralapanawe S; Walkden-Brown SW; Renz KG; Islam AF
Avian Pathol; 2016; 45(1):26-37. PubMed ID: 26503904
[TBL] [Abstract][Full Text] [Related]
9. Deletion of the BAC sequences from recombinant meq-null Marek's disease (MD) virus increases immunosuppression while maintaining protective efficacy against MD.
Su S; Cui N; Li J; Sun P; Li H; Li Y; Cui Z
Poult Sci; 2016 Jul; 95(7):1504-1512. PubMed ID: 26957626
[TBL] [Abstract][Full Text] [Related]
10. Optimizing protocols for monitoring
Faiz NM; Cortes AL; Phang YF; Gimeno IM
Avian Pathol; 2024 Aug; 53(4):303-311. PubMed ID: 38411905
[TBL] [Abstract][Full Text] [Related]
11. A comparative evaluation of the protective efficacy of rMd5deltaMeq and CVI988/ Rispens against a vv+ strain of Marek's disease virus infection in a series of recombinant congenic strains of White Leghorn chickens.
Chang S; Ding Z; Dunn JR; Lee LF; Heidari M; Song J; Ernst CW; Zhang H
Avian Dis; 2011 Sep; 55(3):384-90. PubMed ID: 22017035
[TBL] [Abstract][Full Text] [Related]
12. Sequence analysis of the whole genome of a recombinant Marek's disease virus strain, GX0101, with a reticuloendotheliosis virus LTR insert.
Su S; Cui N; Sun A; Li Y; Ding J; Chen Z; Zhao P; Cui Z
Arch Virol; 2013 Sep; 158(9):2007-14. PubMed ID: 23553452
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a Gallid herpesvirus 2 strain with novel reticuloendotheliosis virus long terminal repeat inserts.
Zhang YP; Bao KY; Sun GR; Lv HC; Cui HY; Gao YL; Wang XM; Liu CJ
Virus Genes; 2017 Jun; 53(3):386-391. PubMed ID: 28194622
[TBL] [Abstract][Full Text] [Related]
14. Serotype 1 viruses modified by backpassage or insertional mutagenesis: approaching the threshold of vaccine efficacy in Marek's disease.
Witter RL; Kreager KS
Avian Dis; 2004 Dec; 48(4):768-82. PubMed ID: 15666858
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a very virulent Marek's disease virus mutant expressing the pp38 protein from the serotype 1 vaccine strain CVI988/Rispens.
Lee LF; Cui X; Cui Z; Gimeno I; Lupiani B; Reddy SM
Virus Genes; 2005 Aug; 31(1):73-80. PubMed ID: 15965611
[TBL] [Abstract][Full Text] [Related]
16. [Isolation and characterization of a non-pathogenic Marek's disease virus with a naturally inserted REV LTR sequence].
Chen R; Luo Q; Guo' K; Liu Z; Li H; Wang J
Wei Sheng Wu Xue Bao; 2014 Jun; 54(6):670-8. PubMed ID: 25272816
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of immunoprotection between vaccination with meq-deleted Marek's disease virus and vaccine strain CVI988/Rispens].
Duan L; Su S; Wang Y; Li S; Sun P; Chen W; Cui Z
Wei Sheng Wu Xue Bao; 2014 Nov; 54(11):1353-61. PubMed ID: 25752142
[TBL] [Abstract][Full Text] [Related]
18. Host genetic resistance to Marek's disease sustains protective efficacy of herpesvirus of turkey in both experimental and commercial lines of chickens.
Chang S; Xie Q; Dunn JR; Ernst CW; Song J; Zhang H
Vaccine; 2014 Apr; 32(16):1820-7. PubMed ID: 24530405
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Gallid herpesvirus 2 with interrupted meq genes confers safe and efficacious protection against virulent field strains.
Zhang Y; Liu C; Yan F; Liu A; Cheng Y; Li Z; Sun G; Lv H; Wang X
Vaccine; 2017 Aug; 35(36):4695-4701. PubMed ID: 28754487
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens.
Lee LF; Kreager KS; Arango J; Paraguassu A; Beckman B; Zhang H; Fadly A; Lupiani B; Reddy SM
Vaccine; 2010 Feb; 28(5):1294-9. PubMed ID: 19941987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
